ICH stability chambers with continuous monitoring for long-term, intermediate, and accelerated studies supporting FDA ...

WASHINGTON, DC - JANUARY 31: President Donald Trump holds up an executive order. Trump spoke to reporters about tariffs against China, Canada and Mexico. He has threatened to impose unprecedented ...

President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting Oct. 1 unless the pharmaceutical company is building a ...

When nearly 20 years ago, the Food and Drug Administration (FDA) issued a new rule 1 that pharmaceutical manufacturers must include a linear bar code on all immediate drug packages that included each ...

The U.S. will impose a 100% tariff on "all any branded or patented Pharmaceutical Product" entering the country from Oct. 1. The measure will not apply to companies building drug manufacturing plants ...

NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today ...

LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug ...

Moderator Shibani Joshi (from left) led a discussion on AI’s role in pharma with Sean Bruich, Mung Chiang, and Tatyana Kanzaveli at the Fast Company Grill during SXSW. BY FastCo Works Before a new ...

In 2025, U.S. had a $112 billion pharmaceutical trade deficit, largely with Ireland and Switzerland. Trump suggested imposing 100% tariffs on certain pharmaceutical imports to reduce this deficit.

America will soon impose "major tariffs" on pharmaceutical imports from other countries, Donald Trump has said. The president revealed his administration's plan at a National Republican Congressional ...

In 2025, the search for innovative pharmaceutical compounds with adaptive performance properties is accelerating. Among the many contenders, Healthletic has positioned itself prominently in the ...